From: Burden, clinical presentation and risk factors of advanced HIV disease in pregnant Mozambican women
Variable | Unadjusted | Adjusted | ||||||
---|---|---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95% CI | P-value | |||
Age group | < 20 | 1 | 0.013 | 1 | 0.029 | |||
20–24 | 1.37 | 0.67; 2.77 | 1.35 | 0.66; 2.76 | ||||
25–34 | 1.89 | 0.99; 3.61 | 1.87 | 0.97; 3.60 | ||||
> 35 | 2.61 | 1.28; 5.33 | 2.52 | 1.21; 5.24 | ||||
Gestational age at the first ANC visit | 0.98 | 0.96; 1.00 | 0.115 | 0.98 | 0.96; 1.01 | 0.146 | ||
ART start | Before first ANC visit | 1 | 0.457 | 1 | 0.180 | |||
After first ANC visit | 1.15 | 0.80; 1.64 | 1.29 | 0.89; 1.87 | ||||
ART Regime | TDF/3TC/EFV | 1 | < 0.001 | 1 | < 0.001 | |||
AZT/3TC/NVP | 3.53 | 2.07; 6.00 | 3.29 | 1.91; 5.67 | ||||
AZT/3TC/LPV/r or ABC | 9.05 | 2.73; 29.97 | 8.59 | 2.56; 28.85 | ||||
Body mass index | 0.97 | 0.93; 1.01 | 0.134 | 0.96 | 0.92; 1.00 | 0.067 |